Anupam Rasayan India Ltd.

Anupam Rasayan gains on signing LoI with Basquevolt, S.A

The parties intend to explore the potential supply of a specialty chemical product over a period of up to 10 years

Anupam Rasayan signs LoI with Basquevolt, S.A

The parties intend to explore the potential supply of a specialty chemical product over a period of up to 10 years

Anupam Rasayan India informs about press release

Anupam Rasayan commercialises ETFA production through flow chemistry platform

ETFA is a critical fluorinated building block and reagent used in the synthesis of a wide range of organic fluorine compounds

Anupam Rasayan India informs about updates

Anupam Rasayan India inches up on raising Rs 160 crore through NCDs

The NCDs are set to mature on June 26, 2027

Anupam Rasayan India raises Rs 160 crore through NCDs

The NCDs are set to mature on June 26, 2027

Anupam Rasayan inks definitive pact to acquire 43.3% stake in Bliss GVS Pharma

This will strategically strengthen the company’s presence across the pharmaceutical value chain, spanning KSMs to finished dosage formulations

Anupam Rasayan India reports Profit after tax of Rs 423.83 Mln, in the March 2026 quarter